From: Conversion of haemodialysis patients from iron sucrose to iron isomaltoside: a real-world experience
Number of doses prescribed | Mild / moderate adverse event* | Severe adverse event* | Event rate per 1000 doses | |
---|---|---|---|---|
Iron sucrose | 14,685 | 7 | 0 | 0.48 |
Iron isomaltoside | 41,295 | 7 | 0 | 0.17 |